Commercial and clinical stage company with novel biologics and advanced therapy products. Fueled by our potential blockbuster, best-in-disease Phase 3 lead product and a robust pipeline of Phase 2 assets, we are delivering breakthrough, life-changing medicines globally to treat patients suffering from autoimmune, cancer and other serious diseases.